Bamboo Extract in the Prevention of Diabetes and Breast Cancer

Complementary and Alternative Therapies and the Aging Population

Volumn , Issue , 2009, Pages 159-177

  Panee, Jun ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855586948     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374228-5.00009-3     Document Type: Chapter

References (108)

1. Sakai S., Saito G., Sugayama J., Kamasuka T., Takada S., Takano T. [on the Anticancer Action of Bamboo Extract.]. J Antibiot [B] 1963, 16:387-391.
2. Shibata M., Yamatake Y., Sakamoto M., Kanamori M., Takagi K. [Phamacological studies on bamboo grass (1). Acute toxicity and anti-inflammatory and antiulcerogenic activities of water-soluble fraction (Folin) extracted from Sasa albomarginata Makino et Shibata]. Nippon Yakurigaku Zasshi 1975, 71:481-490.
3. Shibata M., Kubo K., Onoda M. [Pharmacological studies on bamboo grass. (2) Central depressant and antitoxic actions of a water-soluble fraction (folin) extracted from Sasa albomarginata Makino et Shibata]. Nippon Yakurigaku Zasshi 1976, 72:531-541.
4. Shibata M., Kubo K., Onoda M. [Pharmacological studies on bamboo grass. III. Effects on cardiovascular and isolated organs of water-soluble fraction extracted from Sasa albomarginata Makino et Shibata (Bambusaceae) (author's transl)]. Yakugaku Zasshi 1978, 98:1436-1440.
5. Shibata M., Fojii M., Yamaguchi R. [Pharmacological studies on bamboo grass. IV. Toxicological and pharmacological effects of the extract (FIII) obtained from Sasa albomarginata Makino et Shibata (author's transl)]. Yakugaku Zasshi 1979, 99:663-668.
6. Okabe S., Takeuchi K., Takagi K., Shibata M. Stimulatory effect of the water extract of bamboo grass (Folin solution) on gastric acid secretion in pylorus-ligated rats. Jpn J Pharmacol 1975, 25:608-609.
7. Sato T., Tsuchiya A., Kobayashi N., Kimura J., Hayashi H., Kobayashi H., Hobo R., Kamoi K. [The use in periodontal therapy of a bamboo leaf extract solution]. Nippon Shishubyo Gakkai Kaishi 1986, 28:752-757.
8. Otani K., Yanaura S., Yuda Y., Kawaoto H., Kajita T., Hirano F., Osawa F., Inouye S. Histo-chemical studies on the anti-ulcer effect of bamboo grass in rats. Int J Tissue React 1990, 12:319-332.
9. Tsunoda S., Yamamoto K., Sakamoto S., Inoue H., Nagasawa H. Effects of Sasa health, extract of bamboo grass leaves, on spontaneous mammary tumourigenesis in SHN mice. Anticancer Res 1998, 18:153-158.
10. Hu C., Zhang Y., Kitts D.D. Evaluation of antioxidant and prooxidant activities of bamboo Phyllostachys nigra var. Henonis leaf extract in vitro. J Agric Food Chem 2000, 48:3170-3176.
11. Kweon M.H., Hwang H.J., Sung H.C. Identification and antioxidant activity of novel chlorogenic acid derivatives from bamboo (Phyllostachys edulis). J Agric Food Chem 2001, 49:4646-4655.
12. Kim K.K., Kawano Y., Yamazaki Y. A novel porphyrin photosensitizer from bamboo leaves that induces apoptosis in cancer cell lines. Anticancer Res 2003, 23:2355-2361.
13. Ren M., Reilly R.T., Sacchi N. Sasa health exerts a protective effect on Her2/NeuN mammary tumorigenesis. Anticancer Res 2004, 24:2879-2884.
14. Zhang Y., Wu X., Ren Y., Fu J., Zhang Y. Safety evaluation of a triterpenoid-rich extract from bamboo shavings. Food Chem Toxicol 2004, 42:1867-1875.
15. Kurokawa T., Itagaki S., Yamaji T., Nakata C., Noda T., Hirano T., Iseki K. Antioxidant activity of a novel extract from bamboo grass (AHSS) against ischemia-reperfusion injury in rat small intestine. Biol Pharm Bull 2006, 29:2301-2303.
16. Lu B., Wu X., Shi J., Dong Y., Zhang Y. Toxicology and safety of antioxidant of bamboo leaves. Part 2: Developmental toxicity test in rats with antioxidant of bamboo leaves. Food Chem Toxicol 2006, 44:1739-1743.
17. Zhang Y., Yao X., Bao B., Zhang Y. Anti-fatigue activity of a triterpenoid-rich extract from Chinese bamboo shavings (Caulis bamfusae in taeniam). Phytother Res 2006, 20:872-876.
18. Jiao J., Zhang Y., Lou D., Wu X., Zhang Y. Antihyperlipidemic and antihypertensive effect of a triterpenoid-rich extract from bamboo shavings and vasodilator effect of friedelin on phenylephrine-induced vasoconstriction in thoracic aortas of rats. Phytother Res 2007, 21:1135-1141.
19. Park H.S., Lim J.H., Kim H.J., Choi H.J., Lee I.S. Antioxidant flavone glycosides from the leaves of Sasa borealis. Arch Pharm Res 2007, 30:161-166.
20. Lu B., Wu X., Shi J., Dong Y., Zhang Y. Toxicology and safety of antioxidant of bamboo leaves. Part 2: Developmental toxicity test in rats with antioxidant of bamboo leaves. Food Chem Toxicol 2006, 44:1739-1743.
21. Lu B., Wu X., Tie X., Zhang Y. Toxicology and safety of anti-oxidant of bamboo leaves. Part 1: Acute and subchronic toxicity studies on anti-oxidant of bamboo leaves. Food Chem Toxicol 2005, 43:783-792.
22. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., Flegal K.M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004, 291:2847-2850.
23. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
24. Mokdad A.H., Ford E.S., Bowman B.A., Nelson D.E., Engelgau M.M., Vinicor F., Marks J.S. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 2000, 23:1278-1283.
25. Boyle J.P., Honeycutt A.A., Narayan K.M., Hoerger T.J., Geiss L.S., Chen H., Thompson T.J. Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001, 24:1936-1940.
26. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
27. Cacicedo J.M., Benjachareowong S., Chou E., Ruderman N.B., Ido Y. Palmitate induced apoptosis in cultured bovine retinal pericytes: Roles of NAD(P)H oxidase, oxidant stress, and ceramide. Diabetes 2005, 54:1838-1845.
28. Sims E.A., Danforth E., Horton E.S., Bray G.A., Glennon J.A., Salans L.B. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 1973, 29:457-496.
29. Beck-Nielsen H., Pedersen O., Lindskov H.O. Normalization of the insulin sensitivity and the cellular insulin binding during treatment of obese diabetics for one year. Acta Endocrinol (Copenh) 1979, 90:103-112.
30. Freidenberg G.R., Reichart D., Olefsky J.M., Henry R.R. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J Clin Invest 1988, 82:1398-1406.
31. Bak J.F., Moller N., Schmitz O., Saaek A., Pedersen O. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: Effects of diet treatment. Diabetologia 1992, 35:777-784.
32. Unger R.H. Lipotoxic diseases. Annu Rev Med 2002, 53:319-336.
33. Dyck D.J., Heigenhauser G.J., Bruce C.R. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf) 2006, 186:5-16.
34. Tilg H., Moschen A.R. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
35. Unger R.H., Zhou Y.T. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001, 50(Suppl 1):S118-121.
36. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., Nadal-Ginard B., Anversa P. Myocardial cell death in human diabetes. Circ Res 2000, 87:1123-1132.
37. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes. Proc Natl Acad Sci U S A 1998, 95:2498-2502.
38. Rosenthal M.D. Accumulation of neutral lipids by human skin fibroblasts: Differential effects of saturated and unsaturated fatty acids. Lipids 1981, 16:173-182.
39. Zhang C.L., Lyngmo V., Nordoy A. The effects of saturated fatty acids on endothelial cells. Thromb Res 1992, 65:65-75.
40. de Vries J.E., Vork M.M., Roemen T.H., de Jong Y.F., Cleutjens J.P., van der Vusse G.J., van Bilsen M. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 1997, 38:1384-1394.
41. Rachek L.I., Musiyenko S.I., LeDoux S.P., Wilson G.L. Palmitate induced mitochondrial deoxyribonucleic acid damage and apoptosis in l6 rat skeletal muscle cells. Endocrinology 2007, 148:293-299.
42. Perseghin G., Scifo P., De Cobelli F., et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: A 1H- 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999, 48:1600-1606.
43. Panee J., Liu W., Lin Y., Gilman C., Berry M.J. A novel function of bamboo extract in relieving lipotoxicity. Phytother Res 2008, In press.
44. Brody J.G., Moysich K.B., Humblet O., Attfield K.R., Beehler G.P., Rudel R.A. Environmental pollutants and breast cancer: Epidemiologic studies. Cancer 2007, 109:2667-2711.
45. Phillips D.H. Fifty years of benzo(a)pyrene. Nature 1983, 303:468-472.
46. Phillips D.H. Polycyclic aromatic hydrocarbons in the diet. Mutation Res 1999, 443:139-147.
47. Menzie C.A., Potocki B.B., Santodonato J. Exposure to carcinogenic PAHs in the environment. Environ Sci Technol 1992, 26:1278-1284.
48. Rudel R.A., Attfield K.R., Schifano J.N., Brody J.G. Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer 2007, 109:2635-2666.
49. Heimann R., Heuson J.C., Coune A. Tumors developing in oophorectomized Sprague-Dawley rats after a single gastric instillation of 7,12-dimethylbenz(a)anthracene. Cancer Res 1968, 28:309-313.
50. Kleiner H.E., Vulimiri S.V., Hatten W.B., Reed M.J., Nebert D.W., Jefcoate C.R., DiGiovanni J. Role of cytochrome P450 1 family members in the metabolic activation of polycyclic aromatic hydrocarbons in mouse epidermis. Chem Res Toxicol 2004, 17:1667-1674.
51. Han E.H., Kim J.Y., Jeong H.G. Effect of biochanin A on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Arch Pharm Res 2006, 29:570-576.
52. Granberg L., Ostergren A., Brandt I., Brittebo E.B. CYP1A1 and CYP1B1 in blood-brain interfaces: CYP1A1-dependent bioactivation of 7,12-dimethylbenz(a)anthracene in endothelial cells. Drug Metab Dispos 2003, 31:259-265.
53. Dipple A., Cheng S.C., Bigger C.A.H. Polycyclic aromatic hydrocarbon carcinogens. Prog Clin Biol Res 1990, 347:109-127.
54. Vater S.T., Baldwin D.M., Warshawsky D. Hepatic metabolism of 7,12-dimethylbenz(a)anthracene in male, female, and ovariectomized Sprague-Dawley rats. Cancer Res 1991, 51:492-498.
55. Moore C.J., Tricomi W.A., Gould M.N. Comparison of 7, 12-dimethylbenz(a)anthracene metabolism and DNA binding in mammary epithelial cells from three rat strains with differing susceptibilities to mammary carcinogenesis. Carcinogenesis 1988, 9:2099-2102.
56. Singletary K.W., Parker H.M., Milner J.A. Identification and in vivo formation of 32P-postlabeled rat mammary DMBA-DNA adducts. Carcinogenesis 1990, 11:1959-1963.
57. Daniel F.B., Joyce N.J. DNA adduci formation by 7,12-dimethylbenz(a)anthracene and its noncarcinogenic 2-fiuoro analogue in female Sprague-Dawley rats. J Natl Cancer Inst 1983, 70:111-118.
58. Singletary K.W. Effect of dietary butylated hydroxytoluene on the in vivo distribution, metabolism, and DNA-binding of 7.12-dimethylbenz(a)anthracene. Cancer Lett 1990, 49:187-193.
59. Pool-Zobel B., Veeriah S., Bohmer F.D. Modulation of xenobiotic metabolizing enzymes by anticarcinogens - focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res 2005, 591:74-92.
60. Rundle A., Tang D., Zhou J., Cho S., Perera F. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon- DNA adducts in breast tissue. Cancer Epidemiol Biomarkers Prev 2000, 9:1079-1085.
61. Chang T.W., Wang S.M., Guo Y.L., Tsai P.C., Huang C.J., Huang W. Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan. Breast 2006, 15:754-761.
62. Lampe J.W. Diet, genetic polymorphisms, detoxification, and health risks. Altern Ther Health Med 2007, 13:S108-111.
63. Sparks R., Ulrich C.M., Bigler J., et al. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res 2004, 6:R488-498.
64. Weinshilboum R.M., Otterness D.M., Aksoy I.A., Wood T.C., Her C., Raftogianis R.B. Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. FASEB J 1997, 11:3-14.
65. Adjei A.A., Weinshilboum R.M. Catecholestrogen sulfation: Possible role in carcinogenesis. Biochem Biophys Res Commun 2002, 292:402-408.
66. Falany J.L., Falany C.N. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res 1996, 56:1551-1555.
67. Lin Y., Collier A., Liu W., Berry M.J., Panee J. The inhibitory effect of bamboo extract on the development of 7,12-Dimethylbenz[a]anthracene (DMBA)-induced breast cancer and its regulatory effect on sulfotransferase activity. Phytother Res 2007, In press.
68. Mulder G.J., Van Doorn A.B.D. A rapid NAD+-linked assay for microsomal uridine diphosphate glucuronosyl transferase of Rat liver and some observations on substrate specificity of the enzyme. Biochem J 1975, 151:131-140.
69. Tabrett C.A., Coughtrie M.W. Phenol sulfotransferase 1A1 activity in human liver: Kinetic properties, interindividual variation and re-evaluation of the suitability of 4-nitrophenol as a probe substrate. Biochem Pharmacol 2003, 66:2089-2097.
70. Collier A.C., Tingle M.D., Keelan J.A., Paxton J.W., Mitchell M.D. A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines. Drug Metabol Disp 2000, 28:1184-1186.
71. Gonzalez P., Tunon M.J., Manrique V., Garcia-Pardo L.A., Gonzalez J. Changes in hepatic cytosolic glutathione-S-transferase enzymes induced by clotrimazole treatment in rats. Clin Exp Pharmacol Physiol 1989, 16:867-871.
72. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione-S-Transferases. J Biol Chem 1974, 249:7130-7139.
73. Friedenreich C.M. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001, 10:15-32.
74. Stephenson G.D., Rose D.P. Breast cancer and obesity: an update. Nutr Cancer 2003, 45:1-16.
75. Carmichael A.R. Obesity and prognosis of breast cancer. Obes Rev 2006, 7:333-340.
76. Harvie M., Hooper L., Howell A.H. Central obesity and breast cancer risk: A systematic review. Obes Rev 2003, 4:157-173.
77. Toniolo P.G., Levitz M., Zeleniuch-Jacquotte A., Banerjee S., Koenig K.L., Shore R.E., Strax P., Pasternack B.S. A prospective study of endogenous estrogens and breast cancer in post-menopausal women. J Natl Cancer Inst 1995, 86:1076-1082.
78. Berrino F., Muti P., Micheli A., Bolelli G., Krogh V., Sciajno R., Pisani P., Panico S., Secreto G. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996, 88:291-296.
79. Shimizu H., Ross R.K., Bernstein L., Pike M.C., Henderson B.E. Serum oestrogen levels in postmenopausal women: Comparison of American whites and Japanese in Japan. Br J Cancer 1990, 62:451-453.
80. Bernstein L., Ross R.K., Pike M.C., Brown J.B., Henderson B.E. Hormone levels in older women: A study of post-menopausal breast cancer patients and healthy population controls. Br J Cancer 1990, 61:298-302.
81. Bernstein L., Yuan J.M., Ross R.K., Pike M.C., Hanisch R., Lobo R., Stanczyk F., Gao Y.T., Henderson B.E. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles; results from two breast cancer case-control studies. Cancer Causes Control 1990, 1:51-58.
82. Feigelson H.S., Henderson B.E. Estrogens and breast cancer. Carcinogenesis 1996, 17:2279-2284.
83. Bernstein L. The epidemiology of breast cancer. LOWAC J 1998, 1:7-13.
84. Liehr J.G. Is estradiol a genotoxic mutagenic carcinogen?. Endocr Rev 2000, 21:40-54.
85. Yager J.D., Davidson N.E. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006, 354:270-282.
86. Mitrunen K., Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 2003, 544:9-41.
87. Thompson P.A., Ambrosone C. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 2000, 27:125-134.
88. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997, 94:10937-10942.
89. Kisselev P., Schunck W.H., Roots I., Schwarz D. Association of CYP1A1 polymorphisms with differential metabolic activation of 17 beta-estradiol and estrone. Cancer Res 2005, 65:2972-2978.
90. Symonds D.A., Miller K.P., Tomic D., Flaws J.A. Effect of methoxychlor and estradiol on cytochrome P450 enzymes in the mouse ovarian surface epithelium. Toxicol Sci 2006, 89:510-514.
91. Spink D.C., Katz B.H., Hussain M.M., Pentecost B.T., Cao Z., Spink B.C. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 2003, 24:1941-1950.
92. Katzenellenbogen B.S. Estrogen receptors: Bioactivity and interactions with cell signaling pathways. Biol Reprod 1996, 54:287-293.
93. Liehr J.G., Sirbasku D.A., Jurka E., Randerath K., Randerath E. Inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by Tamoxifen without decrease in DNA adduct levels. Cancer Res 1988, 48:779-783.
94. Wani M.A., Zhu Q., El-Mahdy M., Venkatachalam S., Wani A.A. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells. Cancer Res 2000, 60:2273-2280.
95. Lorincz A.M., Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 2006, 13:279-292.
96. Grodin J.M., Siiteri P.K., MacDonald P.C. Source of estrogen production in postmenopausal women. J Clin Endocrin Metab 1973, 36:207-214.
97. Goodwin P.J., Ennis M., Pritchard K.I., Trudeau M.E., Koo J., Madarnas Y., Hartwick W., Hoffman B., Hood N. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002, 20:42-51.
98. Pugeat M., Crave J.C., Elmidani M., Nicolas M.H., Garoscio-Cholet M., Lejeune H., Dechaud H., Tourniaire J. Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin. J Steroid Biochem Mol Biol 1991, 40:841-849.
99. McTiernan A., Rajan K.B., Tworoger S.S., et al. Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 2003, 21:1961-1966.
100. Hotamisligil G.S. Inflammatory pathways and insulin action. Int JObes Relat Metab Disord 2003, 27:S53-S55.
101. Purohit A., Newman S.P., Reed M.J. The role of cytokines in regulating estrogen synthesis: Implications for the etiology of breast cancer. Breast Cancer Res 2002, 4:65-69.
102. Purohit A., Reed M.J. Regulation of estrogen synthesis in postmenopausal women. Steroids 2002, 67:979-983.
103. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
104. Grano M., Mori G., Minielli V., Cantatore F.P., Colucci S., Zallone A.Z. Breast cancer cell line MDA-231stimulates osteoclastogenesis and bone resorption in human osteoclasts. Biochem Biophys Res Comm 2000, 270:1097-1100.
105. Bachelot T., Ray-Coquard I., Menetrier-Caux C., Rastkha M., Duc A., Blay J.Y. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer 2003, 88:1721-1726.
106. de Nascimento C.O., Hunter L., Trayhurn P. Regulation of haptoglobin gene expression in 3T3-L1 adipocytes by cytokines, catecholamines, and PPARgamma. Biochem Biophys Res Comm 2004, 313:702-708.
107. Vozarova B., Weyer C., Hanson K., Tataranni P.A., Bogardus C., Pratley R.E. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obesity Res 2001, 9:414-417.
108. You T., Yang R., Lyles M.F., Gong D., Nicklas B.sJ. Abdominal adipose tissue cytokine gene expression: Relationship to obesity and metabolic risk factors. Am JPhysiol Endocrinol Metabol 2005, 288:E741-E747.